Supplemental material
Journal of Medical Economics
Volume 27, 2024 - Issue 1
Open access
139
Views
0
CrossRef citations to date
0
Altmetric
Immunology
The economic impact of suboptimal treatment and treatment switch among patients with Crohn’s disease treated with a first-line biologic – A US retrospective claims database study
Patrick Gagnon-Sanschagrina Analysis Group Inc, Montreal, CanadaCorrespondence[email protected]
, Myrlene Sanonb Janssen Global Services LLC, Raritan, NJ, USA
, Mikhaïl Davidsona Analysis Group Inc, Montreal, Canada
, Cynthia Willeyc University of Rhode Island, Kingston, RI, USA
, Sumesh Kachrood Janssen Scientific Affairs LLC, Horsham, PA, USA
, Timothy Hoopsb Janssen Global Services LLC, Raritan, NJ, USA
, Dominik Naessense Janssen Pharmaceutica NV, Beerse, Belgium
, Annie Guerina Analysis Group Inc, Montreal, Canada
& Martin Cloutiera Analysis Group Inc, Montreal, Canada
show all
Pages 931-940
|
Received 12 Apr 2024, Accepted 27 Jun 2024, Published online: 16 Jul 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.